CAPITAL PHARMACY — Budesonide Importer Profile
Pharmaceutical Importer · #13 buyer for Budesonide · $796.5K import value · 26 shipments · OMAN · DGFT Verified
CAPITAL PHARMACY is the #13 importer of Budesonide from India with $796.5K in import value and 26 verified shipments. CAPITAL PHARMACY holds a 0.6% market share in Budesonide imports based in OMAN. The company sources from 1 verified supplier across 16 formulations shipped to 1 country. Overall, CAPITAL PHARMACY imports 2 pharmaceutical products worth $2.3M across 2 therapeutic categories.
CAPITAL PHARMACY — Budesonide Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Budesonide to CAPITAL PHARMACY?
Verified from 26 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| CIPLA LIMITED | $796.5K | 26 | 100.0% |
CAPITAL PHARMACY sources Budesonide from 1 verified Indian supplier based on 26 customs records. The primary supplier is CIPLA LIMITED accounting for 100.0% of imports.
How Does CAPITAL PHARMACY Compare to Nearest Budesonide Importers?
Buyers ranked immediately above and below #13 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | CIPLA USA INC UPS SUPPLY CHAIN SOL | UNITED STATES | $1.3M | 26 | $50.0K |
| 9 | ESPARMA PHARMA SERVICES GMBH | GERMANY | $1.1M | 22 | $50.0K |
| 13 | CAPITAL PHARMACY ★ | OMAN | $1.1M | 22 | $50.0K |
| 5 | EXELAN PHARMACEUTICALS, INC | UNITED STATES | $950.0K | 19 | $50.0K |
| 17 | BREATHEFREE LANKA PRIVATE LIMITED | SRI LANKA | $816.6K | 21 | $38.9K |
CAPITAL PHARMACY ranks #13 among 609 Budesonide importers from India. Average shipment value of $50.0K compared to the market average of $60.8K. The closest competitors by value are CIPLA USA INC UPS SUPPLY CHAIN SOL and ESPARMA PHARMA SERVICES GMBH.
Where Does CAPITAL PHARMACY Import Budesonide To?
Destination countries from 26 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| OMAN | $796.5K | 26 | 100.0% |
CAPITAL PHARMACY imports Budesonide to 1 country. The primary destination is OMAN receiving 100.0% of shipments worth $796.5K.
What Budesonide Formulations Does CAPITAL PHARMACY Import?
| Formulation | Value | Shipments |
|---|---|---|
| BUDECORT 0.5 MG RESPULES/BUDESONIDE NEBU | $272.1K | 6 |
| BUDESONIDE INHALATION SUSPENSION 0.5MG/2ML NDC No. 69097-319-87 ANDA No. 205710 (INV.QTY.5496 PACK 6X5X2 ML=164880 NONOS | $114.9K | 3 |
| BUDESONIDE INHALATION SUSPENSION 0.5MG/2 | $100.0K | 2 |
| FORACORT 200 INHALER CFC FREE FORMOTEROL FUMARATE 6 MCG + BUDESONIDE 200 MCG | $50.0K | 1 |
| BUDESONIDE INHALATION SUSPENSION 0.5MG/2ML NDC NO. 69097-319-87 ANDA NO. 205710 INV.QTY.3288 PACK 6X5X2ML=98640 NOS | $50.0K | 1 |
| FORACORT 200 INHALER (CFC FREE) (FORMOTEROL FUMARATE 6 MCG + BUDESONIDE 200 MCG)NOS | $50.0K | 1 |
| FORACORT 200 INHALER CFC FREE FORMOTEROL FUMARATE 6MCG BUDESONIDE 200MCG 1 X 120 MD | $39.7K | 1 |
| FORACORT 200 INHALER (CFC FREE) (FORMOTEROL FUMARATE 6 MCG + BUDESONIDE 200 MCG | $37.2K | 2 |
| BUDESONIDE INHALATION SUSPENSION 0.5MG/2ML NDC NO. 69097-319-87 ANDA NO. 205710 INV.QTY.1680 PACK 6X5X2ML=50400 NOS | $35.2K | 1 |
| FORACORT 200 INHALER (CFC FREE) (FORMOTEROL FUMARATE 6 MCG + BUDESONIDE 200 MCG) (1 X 120 MD) | $19.1K | 1 |
CAPITAL PHARMACY imports 16 distinct Budesonide formulations from India. The top formulation is BUDECORT 0.5 MG RESPULES/BUDESONIDE NEBU with 6 shipments worth $272.1K.
Who Are the Top Buyers of Budesonide from India and How Much Does CAPITAL PHARMACY Import?
India exported $37.0M worth of Budesonide through 9,145 shipments from 275 suppliers to 115 countries, serving 609 buyers globally. CAPITAL PHARMACY imports $796.5K of this total, accounting for 0.6% of India's Budesonide exports with 26 shipments from OMAN. This is verified from 26 customs shipment records covering 16 distinct formulations.
What Is the Average Order Value for CAPITAL PHARMACY's Budesonide Imports?
CAPITAL PHARMACY's average Budesonide order value is $30.6K per consignment, based on 26 shipments totaling $796.5K. CAPITAL PHARMACY is based in OMAN and ranks #13 among all Budesonide importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Budesonide to CAPITAL PHARMACY?
CAPITAL PHARMACY sources Budesonide from 1 verified Indian supplier: CIPLA LIMITED ($796.5K, 100.0%). This is based on 26 customs records.
How Does CAPITAL PHARMACY Compare to Other Budesonide Importers?
CAPITAL PHARMACY ranks #13 among 609 Budesonide importers from India with a 0.6% market share. The top 3 importers are CIPLA USA INC UPS SUPPLY CHAIN SOLU ($16.6M), BIOPHARM DISTRIBUTION SPA ($3.0M), ACINO PHARMACEUTICALS FZ LLC ($2.4M). CAPITAL PHARMACY processed 26 shipments from OMAN.
About CAPITAL PHARMACY
CAPITAL PHARMACY imports 2 products worth $2.3M. Beyond Budesonide, top products include Lansoprazole. View the complete CAPITAL PHARMACY profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Budesonide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Budesonide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: CAPITAL PHARMACY matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as CAPITAL PHARMACY's capped import value divided by total capped export value for Budesonide across all Indian exporters.
- 5.Verified Records: This page is backed by 26 individual customs records matching CAPITAL PHARMACY importing Budesonide, covering 16 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 115+ countries, 609+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Budesonide Import Data for CAPITAL PHARMACY
Access order-level details, pricing data, supplier connections, and competitive analysis for CAPITAL PHARMACY's Budesonide imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
CAPITAL PHARMACY
Full Company Profile →
2 products · $2.3M total trade · 2 categories
CAPITAL PHARMACY × Budesonide
Verified from customs records
Company Overview
Top Products by CAPITAL PHARMACY
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for CAPITAL PHARMACY.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Budesonide. For current order-level data, contact TransData Nexus.